Literature DB >> 25082836

Outcomes of patients undergoing concomitant mitral and aortic valve surgery: results from an Italian regional cardiac surgery registry.

Francesco Nicolini1, Andrea Agostinelli2, Daniela Fortuna3, Giovanni Andrea Contini2, Davide Pacini4, Davide Gabbieri5, Claudio Zussa6, Florio Pigini7, Rossana De Palma3, Tiziano Gherli8.   

Abstract

OBJECTIVES: There are limited reliable data on the long-term survival of patients operated upon with double-valve surgery (DVS) in the literature. In this study, in-hospital mortality and 5-year survival were determined and the potential risk factors for increased mortality were identified and discussed.
METHODS: This is a report of an observational retrospective study of 1167 patients undergoing concomitant aortic and mitral valve surgery from 2002 to 2011. Data were prospectively collected in a regional database from Emilia-Romagna (Italy).
RESULTS: The overall in-hospital mortality rate for DVS was 6.9%. Both in-hospital and 1-year mortality were statistically significant between age groups. In-hospital mortality was significantly higher for patients with a smaller body mass index (BMI), for those who had concomitant coronary artery bypass grafting (CABG) and those who received mitral valve replacement (MVR) instead of plasty (MVP). In-hospital and 1-year mortality were highest in patients ≥70 who had implantation of mitral and aortic mechanical valves. There were significant differences in 5-year follow-up survival according to age, BMI and concomitant CABG. The choice of MVR and MVP did not affect 5-year survival. Multivariable analysis showed that patient-related factors appear to be the major determinant of late survival, irrespective of the type of operation or other intraoperative variables.
CONCLUSIONS: Advanced age, smaller BMI and concomitant CABG are significant risk factors for mortality in DVS. MVP provided comparable 5-year outcomes with MVR. Multivariable analysis demonstrates that preoperative and clinical patient-related factors are the real burden in the successful treatment of patients undergoing double-valve procedures.
© The Author 2014. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Entities:  

Keywords:  Aortic valve; Cardiac surgery; Mitral valve; Valve prostheses

Mesh:

Year:  2014        PMID: 25082836     DOI: 10.1093/icvts/ivu248

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  4 in total

1.  Medium-term outcomes of 78,808 patients after heart valve surgery in a middle-income country: a nationwide population-based study.

Authors:  Regina Maria de Aquino Xavier; Vitor Manuel Pereira Azevedo; Paulo Henrique Godoy; Arn Migowski; Antonio Luiz Pinho Ribeiro; Rogério Brant Martins Chaves; Marcelo Goulart Correia; Carolina de Aquino Xavier; Lucas de Aquino Hashimoto; Clara Weksler; Nelson Albuquerque Souza E Silva
Journal:  BMC Cardiovasc Disord       Date:  2017-12-28       Impact factor: 2.298

2.  Should high risk patients with concomitant severe aortic stenosis and mitral valve disease undergo double valve surgery in the TAVR era?

Authors:  Pey-Jen Yu; Allan Mattia; Hugh A Cassiere; Rick Esposito; Frank Manetta; Nina Kohn; Alan R Hartman
Journal:  J Cardiothorac Surg       Date:  2017-12-29       Impact factor: 1.637

Review 3.  The Prospects of Secondary Moderate Mitral Regurgitation after Aortic Valve Replacement -Meta-Analysis.

Authors:  Ilija Bilbija; Milos Matkovic; Marko Cubrilo; Nemanja Aleksic; Jelena Milin Lazovic; Jelena Cumic; Vladimir Tutus; Marko Jovanovic; Svetozar Putnik
Journal:  Int J Environ Res Public Health       Date:  2020-10-08       Impact factor: 3.390

4.  Body mass index and postoperative mortality in patients undergoing coronary artery bypass graft surgery plus valve replacement: a retrospective cohort study.

Authors:  Chun Dai; Hongbo Xu; Tianshu Chu; Boyang Cao; Jianjun Ge
Journal:  PeerJ       Date:  2022-06-14       Impact factor: 3.061

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.